This inventor holds 1 USPTO granted patent. Top assignee: Leuven Research & Development Vzw. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Désiré J Collen
Introduction
Désiré J Collen is a notable inventor based in London, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection and determination of coronary artery disease. His innovative approach has the potential to improve patient outcomes through early and accurate diagnosis.
Latest Patents
Désiré J Collen holds a patent for a method that provides a clinically sufficient degree of diagnostic accuracy for detecting the presence of coronary artery disease in human patients. This method distinguishes between various stages of the disease, including the non-acute stage, unstable angina, and acute myocardial infarction. The detection relies on the clinically significant presence of specific markers in patient samples, such as OxLDL, MDA-modified LDL, and troponin. This innovative diagnostic method is crucial for timely medical intervention.
Career Highlights
Désiré J Collen is associated with Leuven Research & Development Vzw, where he continues to advance his research and innovations. His work focuses on enhancing diagnostic techniques that can lead to better management of coronary artery disease. His dedication to improving healthcare through innovation is evident in his patent and ongoing research efforts.
Collaborations
Désiré J Collen collaborates with Paul N Holvoet, a fellow researcher who shares his commitment to advancing medical diagnostics. Their partnership exemplifies the importance of teamwork in driving innovation in healthcare.
Conclusion
Désiré J Collen's contributions to the field of medical diagnostics, particularly in coronary artery disease detection, highlight the impact of innovative thinking in healthcare. His patent represents a significant advancement that could lead to better patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile